Truls Sylvan Ingebrigtsen
Overview
Explore the profile of Truls Sylvan Ingebrigtsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rastoder E, Sivapalan P, Eklof J, Saeed M, Svorre Jordan A, Meteran H, et al.
Biomedicines
. 2021 Aug;
9(8).
PMID: 34440079
Due to frequent exacerbations, many patients with chronic obstructive pulmonary disease (COPD) are exposed to oral corticosteroids (OCS), which may be thrombogenic. We evaluated the risk of hospitalisation with venous...
12.
Marott J, Ingebrigtsen T, Colak Y, Vestbo J, Lange P
Am J Respir Crit Care Med
. 2021 Jul;
204(8):910-920.
PMID: 34233141
Natural history of preserved ratio impaired spirometry (PRISm), often defined as FEV/FVC ⩾lower limit of normal and FEV <80% of predicted value, is not well described. To investigate the natural...
13.
Ingebrigtsen T, Marott J, Vestbo J, Nordestgaard B, Lange P
BMJ Open Respir Res
. 2020 Dec;
7(1).
PMID: 33371008
Introduction: We investigated risk of coronary heart disease and heart failure in phenotypes of obstructive airway disease. Methods: Among 91 692 participants in the Copenhagen General Population Study, 42 058...
14.
Marott J, Ingebrigtsen T, Colak Y, Vestbo J, Lange P
Am J Respir Crit Care Med
. 2020 Apr;
202(2):210-218.
PMID: 32289231
Chronic obstructive pulmonary disease (COPD) can develop not only through a lung function trajectory dominated by an accelerated decline of FEV from normal maximally attained FEV in early adulthood (normal...
15.
Eklof J, Gliese K, Ingebrigtsen T, Bodtger U, Jensen J
PLoS One
. 2020 Jan;
14(12):e0226935.
PMID: 31891624
Objective: The effect of antibiotics on survival in patients with pulmonary Pseudomonas aeruginosa is controversial. The aim of this study is to i) determine the prevalence of adequate antibiotic treatment...
16.
Ingebrigtsen T, Vestbo J, Rode L, Marott J, Lange P, Nordestgaard B
Thorax
. 2019 Sep;
74(10):934-940.
PMID: 31481635
Background: Individual susceptibility to exacerbations in chronic obstructive pulmonary disease (COPD) is likely influenced by genetic factors; however, most such variance is unexplained. We hypothesised that β-adrenergic receptor genotypes, Gly16Arg...
17.
Sivapalan P, Ingebrigtsen T, Rasmussen D, Sorensen R, Rasmussen C, Jensen C, et al.
BMJ Open Respir Res
. 2019 Jun;
6(1):e000407.
PMID: 31179005
Introduction: A large group of patients with chronic obstructive pulmonary disease (COPD) are exposed to an overload of oral corticosteroids (OCS) due to repeated exacerbations. This is associated with potential...
18.
Tottenborg S, Lange P, Johnsen S, Nielsen H, Ingebrigtsen T, Thomsen R
Respir Med
. 2016 Oct;
119:160-167.
PMID: 27692139
Background: Low socioeconomic status has been associated with adverse outcomes in chronic obstructive pulmonary disease (COPD), but population-based data are sparse. We examined the impact of education, employment, income, ethnicity,...
19.
Lange P, Colak Y, Ingebrigtsen T, Vestbo J, Marott J
Lancet Respir Med
. 2016 Apr;
4(6):454-62.
PMID: 27061878
Background: Long-term prognosis of patients with characteristics of both chronic obstructive pulmonary disease (COPD) and asthma, named asthma-COPD overlap, is poorly described. We investigated the long-term prognosis of individuals with...
20.
Tottenborg S, Topp M, Ingebrigtsen T, Lange P
Ugeskr Laeger
. 2014 Oct;
176(42).
PMID: 25316358
Non-adherence to medicine is common in patients with chronic diseases, contributing to significant worsening of disease, increased mortality and health expenditure. Methods of measuring adherence include self report, prescription refill...